Differences in verapamil response between CYP3A5 genotypes.

被引：1
|
作者：
Langaee, TY
Yarandi, HN
Katz, DA
Dehoff, RM
Kehoe, JM
Klocman, AS
Pepine, CJ
Johnson, JA
机构：
[1] Univ Florida, Gainesville, FL USA
[2] Abbott Labs, Abbott Pk, IL 60064 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2006年 / 79卷 / 02期
关键词：
D O I：
10.1016/j.clpt.2005.12.043
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P12 / P12
页数：1
相关论文
共 50 条
  • [41] Differences in CYP3A5*3 genotype distribution and combinations with other polymorphisms between Spaniards and other Caucasian populations
    Gervasini, G
    Vizcaino, S
    Gasiba, C
    Carrillo, JA
    Benitez, J
    THERAPEUTIC DRUG MONITORING, 2005, 27 (06) : 819 - 821
  • [42] The distribution of MDR1, CYP3A4 and CYP3A5 genotypes in a polish heart transplant recipients
    Kunicki, Pawel K.
    Sobieszczanska-Malek, Malgorzata
    Gmik, Wanda
    Drozdzik, Marek
    Adler, Grazyna
    Ciechanowicz, Andrzej
    THERAPEUTIC DRUG MONITORING, 2007, 29 (04) : 545 - 545
  • [43] Association Between CYP3A4 and CYP3A5 Genotypes and Cyclosporine's Blood Levels and Doses among Jordanian Kidney Transplanted Patients
    El-Shair, Sahar
    Al Shhab, Mohammad
    Zayed, Khaled
    Alsmady, Moaath
    Zihlif, Malek
    CURRENT DRUG METABOLISM, 2019, 20 (08) : 682 - 694
  • [44] Influence of CYP2D6, CYP3A4 and CYP3A5 genotypes on the pharmacokinetics of bropmeridol and extrapyramidal symptoms
    Lee, SY
    Kim, YG
    Kim, HG
    Kim, JW
    THERAPEUTIC DRUG MONITORING, 2005, 27 (02) : 232 - 232
  • [45] CYP3A5*3 genotypes and advanced non-small cell lung cancer development
    Nogal, A.
    Coelho, A.
    Araujo, A.
    Azevedo, I.
    Faria, A.
    Soares, M.
    Catarino, R.
    Medeiros, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [46] The association between the CYP3A5 genotype and blood pressure.
    Ho, H
    Pinto, A
    Hall, SD
    Flockhart, DA
    Li, L
    Skaar, T
    Wagner, U
    Fineberg, NS
    Weinberger, MH
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P61 - P61
  • [47] MD Investigation on the Interaction between Carbamazepine and Two CYP Isoforms, CYP3A4 and CYP3A5
    Liu, Shuhui
    Xu, Yang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [48] Effects of clotrimazole on tacrolimus pharmacokinetics in patients with heart transplants with different CYP3A5 genotypes
    Uno, Takaya
    Wada, Kyoichi
    Matsuda, Sachi
    Terada, Yuka
    Terakawa, Nobue
    Oita, Akira
    Yokoyama, Satoshi
    Kawase, Atsushi
    Hosomi, Kouichi
    Takada, Mitsutaka
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 (01) : 67 - 75
  • [49] Effects of clotrimazole on tacrolimus pharmacokinetics in patients with heart transplants with different CYP3A5 genotypes
    Takaya Uno
    Kyoichi Wada
    Sachi Matsuda
    Yuka Terada
    Nobue Terakawa
    Akira Oita
    Satoshi Yokoyama
    Atsushi Kawase
    Kouichi Hosomi
    Mitsutaka Takada
    European Journal of Clinical Pharmacology, 2019, 75 : 67 - 75
  • [50] The role of CYP3A5 genotypes in dose requirements of tacrolimus and everolimus after heart transplantation
    Kniepeiss, Daniela
    Renner, Wilfried
    Trummer, Olivia
    Wagner, Doris
    Wasler, Andrae
    Khoschsorur, Gholam A.
    Truschnig-Wilders, Martie
    Tscheliessnigg, Karl-Heinz
    CLINICAL TRANSPLANTATION, 2011, 25 (01) : 146 - 150
12345